• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对卡斯审查的批评:对同行评审文献和灰色文献进行事实核查

Critiques of the Cass Review: Fact-Checking the Peer-Reviewed and Grey Literature.

作者信息

McDeavitt Kathleen, Cohn J, Levine Stephen B

机构信息

Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.

Society for Evidence-Based Gender Medicine, Twin Falls, ID, USA.

出版信息

J Sex Marital Ther. 2025;51(2):175-199. doi: 10.1080/0092623X.2025.2455133. Epub 2025 Feb 4.

DOI:10.1080/0092623X.2025.2455133
PMID:39903043
Abstract

The Cass Review's final report, published in April 2024, made recommendations to the UK's National Health Service regarding structuring of services for minors with gender-related distress. It recommended cautious use of hormonal interventions in this population and use of research protocols. Some clinician-researchers disagree with the Cass Review's recommendations and have written critiques. A critique of the Cass Review posted on Yale Law School's website in July 2024 has received extensive media coverage. Its references identified three other critiques. In these papers, there were multiple claims that were incorrect or that lacked essential clarification/contextualization. These claims involved (1) the Cass Review's contents and processes; (2) the pediatric transgender healthcare evidence base; (3) existing clinical practice guidelines, including claims that there is international medical consensus; (4) evidence-based medical practice and guideline development; and (5) conclusions regarding the validity of the Cass Review's findings. The Cass Review's careful, balanced investigations and judgments were a comprehensive, evidence-based response to the controversies in this pediatric clinical arena. Recently-published critiques of the Review have contained incorrect or inadequately contextualized claims. Because accurate information about medical interventions is essential to informed consent, it is important to correct errors in potentially influential publications.

摘要

卡斯审查的最终报告于2024年4月发布,就为有性别相关困扰的未成年人构建服务体系向英国国家医疗服务体系提出了建议。它建议在这一人群中谨慎使用激素干预措施,并采用研究方案。一些临床研究人员不同意卡斯审查的建议,并撰写了批评意见。2024年7月发表在耶鲁法学院网站上的一篇对卡斯审查的批评文章受到了媒体的广泛报道。其参考文献还指出了其他三篇批评文章。在这些论文中,有多项说法是错误的,或者缺乏必要的阐释/背景信息。这些说法涉及:(1)卡斯审查的内容和流程;(2)儿科跨性别医疗保健的证据基础;(3)现有的临床实践指南,包括声称存在国际医学共识;(4)循证医学实践和指南制定;以及(5)关于卡斯审查结果有效性的结论。卡斯审查细致、平衡的调查和判断是对这一儿科临床领域争议的全面、循证回应。最近发表的对该审查的批评包含了错误或背景信息不充分的说法。由于关于医疗干预的准确信息对于知情同意至关重要,因此纠正有潜在影响力的出版物中的错误很重要。

相似文献

1
Critiques of the Cass Review: Fact-Checking the Peer-Reviewed and Grey Literature.对卡斯审查的批评:对同行评审文献和灰色文献进行事实核查
J Sex Marital Ther. 2025;51(2):175-199. doi: 10.1080/0092623X.2025.2455133. Epub 2025 Feb 4.
2
Gender medicine and the Cass Review: why medicine and the law make poor bedfellows.性别医学与卡斯审查:为何医学与法律并非理想的伙伴。
Arch Dis Child. 2025 Mar 19;110(4):251-255. doi: 10.1136/archdischild-2024-327994.
3
Implications of the Cass Review for health policy governing gender medicine for Australian minors.卡斯审查对澳大利亚未成年人性别医疗健康政策的影响。
Australas Psychiatry. 2025 Feb;33(1):89-95. doi: 10.1177/10398562241276335. Epub 2024 Aug 31.
4
Improving the experience of health services for trans and gender-diverse young people and their families: an exploratory qualitative study.改善跨性别和性别多样化青少年及其家庭的医疗服务体验:一项探索性定性研究。
Health Soc Care Deliv Res. 2025 Feb;13(4):1-130. doi: 10.3310/XCYT6530.
5
Fertility preservation for transgender adolescents and young adults: a systematic review. transgender 青少年和年轻人的生育力保存:系统评价。
Hum Reprod Update. 2019 Nov 5;25(6):694-716. doi: 10.1093/humupd/dmz026.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Clinical guidelines for children and adolescents experiencing gender dysphoria or incongruence: a systematic review of guideline quality (part 1).临床指南:儿童和青少年性别焦虑或不和谐的处理建议:指南质量的系统综述(第 1 部分)。
Arch Dis Child. 2024 Oct 30;109(Suppl 2):s65-s72. doi: 10.1136/archdischild-2023-326499.
8
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.性别焦虑/性别不一致者的内分泌治疗:内分泌学会临床实践指南
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903. doi: 10.1210/jc.2017-01658.
9
Minors Lack the Autonomy to Consent to Gender-Affirming Care: Best Interests Must Be Primary.未成年人缺乏同意性别肯定护理的自主权:首要考虑的必须是最佳利益。
Hastings Cent Rep. 2024 May;54(3):57-58. doi: 10.1002/hast.1600.
10
Commentary: The Signal and the Noise-questioning the benefits of puberty blockers for youth with gender dysphoria-a commentary on Rew et al. (2021).述评:信号与噪声——质疑青春期阻滞剂对性别焦虑青年的益处——对 Rew 等人(2021 年)的评论。
Child Adolesc Ment Health. 2022 Sep;27(3):259-262. doi: 10.1111/camh.12533. Epub 2021 Dec 22.

引用本文的文献

1
Gender-affirming hormone treatment for young people with gender dysphoria: where do we go from here?为患有性别焦虑症的年轻人提供性别肯定激素治疗:我们从这里走向何方?
Arch Dis Child. 2025 May 16;110(6):415-416. doi: 10.1136/archdischild-2025-328478.